{
    "clinical_study": {
        "@rank": "154918", 
        "brief_summary": {
            "textblock": "To compare parenteral versus inhaled pentamidine in patients with documented Pneumocystis\n      carinii pneumonia (PCP) with AIDS."
        }, 
        "brief_title": "A Study of Two Forms of Pentamidine in the Treatment of Pneumocystis Carinii Pneumonia (PCP) in Patients With AIDS", 
        "condition": [
            "Pneumonia, Pneumocystis Carinii", 
            "HIV Infections"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Acquired Immunodeficiency Syndrome", 
                "HIV Infections", 
                "Immunologic Deficiency Syndromes", 
                "Pneumonia", 
                "Pneumonia, Pneumocystis"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Exclusion Criteria\n\n        Co-existing Condition:\n\n        Patients with the following are excluded:\n\n          -  Previous history of adverse reaction to pentamidine.\n\n          -  History of asthma.\n\n          -  Pulmonary Kaposi's sarcoma.\n\n        Patients with the following are excluded:\n\n          -  Previous history of adverse reaction to pentamidine.\n\n          -  History of asthma.\n\n          -  Pulmonary Kaposi's sarcoma.\n\n          -  Inability to understand the consent procedure.\n\n        All patients hospitalized at Cedars-Sinai Medical Center with AIDS and possible\n        Pneumocystis carinii pneumonia (PCP) will be eligible.\n\n          -  Patients with HIV antibody or AIDS and a clinical presentation suggesting PCP are\n             eligible."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "November 2, 1999", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00002292", 
            "org_study_id": "023B", 
            "secondary_id": "88-001"
        }, 
        "intervention": {
            "intervention_name": "Pentamidine isethionate", 
            "intervention_type": "Drug"
        }, 
        "intervention_browse": {
            "mesh_term": "Pentamidine"
        }, 
        "keyword": [
            "AIDS-Related Opportunistic Infections", 
            "Pneumonia, Pneumocystis carinii", 
            "Pentamidine", 
            "Injections, Intravenous", 
            "Administration, Inhalation", 
            "Aerosols", 
            "Acquired Immunodeficiency Syndrome"
        ], 
        "lastchanged_date": "June 23, 2005", 
        "location": {
            "facility": {
                "address": {
                    "city": "Rosemont", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60018"
                }, 
                "name": "LyphoMed Inc"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "official_title": "Inhaled Versus Intravenous Pentamidine in Pneumocystis Carinii Pneumonia in the Acquired Immunodeficiency Syndrome", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Food and Drug Administration"
        }, 
        "phase": "N/A", 
        "reference": [
            {
                "PMID": "2197910", 
                "citation": "Soo Hoo GW, Mohsenifar Z, Meyer RD. Inhaled or intravenous pentamidine therapy for Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann Intern Med. 1990 Aug 1;113(3):195-202. Erratum in: Ann Intern Med 1990 Oct 1;113(7):561."
            }, 
            {
                "PMID": "2197911", 
                "citation": "Conte JE Jr, Chernoff D, Feigal DW Jr, Joseph P, McDonald C, Golden JA. Intravenous or inhaled pentamidine for treating Pneumocystis carinii pneumonia in AIDS. A randomized trial. Ann Intern Med. 1990 Aug 1;113(3):203-9."
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00002292"
        }, 
        "source": "NIH AIDS Clinical Trials Information Service", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "LyphoMed", 
                "agency_class": "Industry"
            }
        }, 
        "study_design": "Allocation: Randomized, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "August 1989"
    }, 
    "geocoordinates": {
        "LyphoMed Inc": "41.989 -87.871"
    }
}